Allograft bone matrix versus synthetic bone graft substitutes

• Verfasst von: Zimmermann, Gerald [VerfasserIn]
• Verfasst von: Moghaddam-Alvandi, Arash [VerfasserIn]
• Titel: Allograft bone matrix versus synthetic bone graft substitutes
• Verf.angabe: Gerald Zimmermann, Arash Moghaddam
• E-Jahr: 2011
• Jahr: 1 September 2011
• Umfang: 6 S.
• Fussnoten: Gesehen am 19.01.2023
• Titel Quelle: Enthalten in: Injury
• Ort Quelle: Amsterdam [u.a.] : Elsevier Science, 1969
• Jahr Quelle: 2011
• Band/Heft Quelle: 42(2011), Supplement 2 vom: Sept., Seite S16-S21
• ISSN Quelle: 1879-0267
• DOI: doi:10.1016/j.injury.2011.06.199
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: Allograft
• Sach-SW: Bone morphogenetic protein
• Sach-SW: Demineralized bone matrix
• Sach-SW: Synthetic bone substitutes
• K10plus-PPN: 1831542080

Abstract

Autologous bone is used very often in the treatment of fresh fractures, delayed unions and non-unions. Alternatives have included allografts and in recent years also demineralized bone matrix. The growing availability of good synthetic bone grafts and their advantages in safety and avoiding donor-site morbidity are the reasons that these products are being used more and more. There are on the market a wide variety of substitutes with different capabilities. Nevertheless autologous bone graft is still considered as the gold standard and will be discussed here in that context. Osteoconductive, osteogenic and osteoinductive products will also be classified and their advantages and disadvantages described.